Fampridin Teva 10 mg tablete s produljenim oslobađanjem Kroatija - kroatų - HALMED (Agencija za lijekove i medicinske proizvode)

fampridin teva 10 mg tablete s produljenim oslobađanjem

teva gmbh, graf-arco-str. 3, ulm, njemačka - fampridin - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 10 mg fampridina

Sitagliptin SUN Europos Sąjunga - kroatų - EMA (European Medicines Agency)

sitagliptin sun

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Artesunate Amivas Europos Sąjunga - kroatų - EMA (European Medicines Agency)

artesunate amivas

amivas ireland ltd - artesunate - malarija - antiprotozoals - artesunate amivas is indicated for the initial treatment of severe malaria in adults and children. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje противомалярийных posrednika.

BONDRONAT 50 mg/1 tableta film tableta Bosnija ir Hercegovina - kroatų - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

bondronat 50 mg/1 tableta film tableta

medicopharmacia d.o.o. sarajevo - ibandronska kiselina - film tableta - 50 mg/1 tableta - 1 film tableta sadrži: 50 mg ibandronska kiselina (u obliku ibandronatnatrijum, monohidrata)

Upstaza Europos Sąjunga - kroatų - EMA (European Medicines Agency)

upstaza

ptc therapeutics international limited - eladocagene exuparvovec - metabolizam aminokiselina, urođene pogreške - enzymes, other alimentary tract and metabolism products - upstaza is indicated for the treatment of patients aged 18 months and older with a clinical, molecular, and genetically confirmed diagnosis of aromatic l amino acid decarboxylase (aadc) deficiency with a severe phenotype (see section 5.

Enjaymo Europos Sąjunga - kroatų - EMA (European Medicines Agency)

enjaymo

sanofi b.v. - sutimlimab - hemolysis; anemia, hemolytic, autoimmune - imunosupresivi - enjaymo is indicated for the treatment of haemolytic anaemia in adult patients with cold agglutinin disease (cad).

Livmarli Europos Sąjunga - kroatų - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

EVRYSDI 0,75 mg/1 mL prašak za oralnu otopinu Bosnija ir Hercegovina - kroatų - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

evrysdi 0,75 mg/1 ml prašak za oralnu otopinu

roche d.o.o.roche ltd. - risdiplam - prašak za oralnu otopinu - 0,75 mg/1 ml - 1 bočica sa 2 g praška za oralnu otopinu sadrži 60 mg risdiplama (1 ml rekonstituirane otopine sadrži 0,75 mg risdiplama)

Omvoh Europos Sąjunga - kroatų - EMA (European Medicines Agency)

omvoh

eli lilly nederland b.v. - mirikizumab - kolitis, ulcerativni - imunosupresivi - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

ESCEPRAN 25mg Film tableta Juodkalnija - kroatų - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

escepran 25mg film tableta

dio stranog druŠtva "krka d.d. novo mesto" slovenija - predstavniŠtvo podgorica - eksemestan - film tableta - 25mg